Application Nr Approved Date Route Status External Links
ANDA091322 2011-07-22 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Carefully Consider The Potential Benefits And Risks Of Mefenamic Acid Capsules And Other Treatment Options Before Deciding To Use Mefenamic Acid Capsules. Use The Lowest Effective Dose For The Shortest Duration Consistent With Individual Patient Treatment Goals (see Warnings; Gastrointestinal Bleeding, Ulceration, And Perforation). Mefenamic Acid Capsules Are Indicated: For Relief Of Mild To Moderate Pain In Patients ≥14 Years Of Age, When Therapy Will Not Exceed One Week (7 Days). For Treatment Of Primary Dysmenorrhea.

All Formulated Excipients (3 Total)

Name Structure Kind Function Status
1. Sodium Lauryl Sulfate SODIUM LAURYL SULFATE Molecular AF-Antifoaming (or defoaming) agent , CTG-Component or coating , EMUL-Emulsifier , SANI-Sanitizing agent , SDA-Solubilizing & dispersing agent REG-Food additives for which a petition has been filed and a regulation issued.
2. Titanium Dioxide TITANIUM DIOXIDE Unresolved DYE-Dye
3. D&c Yellow No. 10 D&C YELLOW NO. 10 Molecular DYE-Dye

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mefenamic Acid MEFENAMIC ACID ZINC20241